ERBB2 and breast carcinoma: In contrast to HER2-negative breast cancer, HER2-positive breast cancer expresses higher levels of EGFR [44] and exhibits increased signaling from HER family receptors, such as EGFR, as well as EGFR/HER2 crosstalk [45].